Ronald Kirk Huntsman, Chief Executive Officer, 10% Owner at Vivos Therapeutics, Inc. (VVOS), bought 500 shares at $8.50 ($4K) on 2020-12-11, disclosed to the SEC on 2020-12-14.
Open-market purchase of $4k VVOS by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| VVOS | BUY | 2023-06-15 | $5K | — | Filing → |
| VVOS | BUY | 2022-12-28 | $10K | — | Filing → |
| VVOS | BUY | 2022-06-03 | $24K | — | Filing → |